July 06, 2026 a 04:38 pm
ALGN: Analysts Ratings - Align Technology, Inc.
Align Technology, Inc. has been a leader in the medical technology field, known for its pioneering Invisalign system and iTero scanners. The company's stock has shown resilience in the face of market volatility, with consistent analyst interest reflected in the ratings. This analysis provides insights into recent analyst recommendations, capturing shifts in sentiment and market positioning.
Historical Stock Grades
| Rating Type | Count | Visualization |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 8 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
Analyzing the trends in analyst recommendations reveals a stable outlook over recent months. The majority sentiment remains positive, with Buy ratings consistently high. The presence of Strong Buy ratings has notably decreased in the last year, reflecting a more cautious optimism among analysts.
- Strong Buy ratings have held steady at 3 in recent months but are lower compared to earlier levels.
- Buy ratings have remained strong throughout the latest data points, showcasing confidence.
- Hold ratings have fluctuated, indicating some market caution.
Percentage Trends
The percentage distribution across various rating categories suggests a shift towards more moderate optimism. While Strong Buy ratings have dipped slightly, Buy and Hold categories have captured most of the analyst sentiment, highlighting a balanced but slightly conservative view.
- Currently, Buy and Strong Buy ratings together account for approximately 65% of total recommendations.
- The Hold category reflects 25% of the recommendations, showing a conservative stance.
- Over the past year, Buy ratings' dominance has been slightly challenged by a steady Hold percentage.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-30 | Outperform | Outperform | Evercore ISI Group |
| 2026-04-24 | Equal Weight | Equal Weight | Morgan Stanley |
| 2026-04-21 | Overweight | Overweight | Piper Sandler |
| 2026-03-17 | Overweight | Equal Weight | Barclays |
| 2026-02-26 | Equal Weight | Equal Weight | Barclays |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-17 | Overweight | Equal Weight | Barclays |
| 2026-02-09 | Buy | Hold | HSBC |
| 2025-10-10 | Hold | Buy | Jefferies |
| 2025-07-31 | Equal Weight | Overweight | Morgan Stanley |
| 2025-04-25 | Hold | Buy | HSBC |
Interpretation
The current sentiment analysis indicates a stable, albeit cautious, positive outlook for Align Technology, Inc. The consistent presence of Buy and Strong Buy ratings suggests continued confidence in the company's growth potential and market position. However, the observed decrease in Strong Buy ratings and steady Hold recommendations indicate some underlying market uncertainties. These shifts suggest that while optimism persists, analysts are adopting a more measured approach in their evaluations.
Conclusion
In conclusion, Align Technology, Inc. exhibits strong market positioning and innovation-driven growth potential. Analysts demonstrate confidence through sustained Buy ratings, but the slight dip in Strong Buy recommendations hints at cautious optimism. The evolving landscape reflects a need for continued monitoring, especially as the medical technology sector faces dynamic shifts. Investors should weigh Align's robust product offerings against market uncertainties, considering both the opportunities and the risks entailed.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years